Bayer Baycol avoids class action
Minneapolis federal court denies plaintiffs' motion for class action certification. Bayer had argued that possible claims would have comprised too many diverse and individual issues. Baycol settlements accelerated following initial favorable trial court decisions for Bayer (1"The Pink Sheet" May 12, 2003, p. 20). The company has settled more than 1,342 cases in the U.S. to date...
You may also be interested in...
Bayer has seen the pace of Baycol-related settlements quicken following favorable decisions in the first two cases to come to trial, Finance Division Head Klaus Kühn said during Bayer's May 7 quarterly earnings call
Representatives from cardiac monitoring device manufacturers and professional societies are working together to persuade Medicare carrier Novitas to reconsider its payment rates for extended cardiac monitoring. See what Michael Coyle, iRhythm’s CEO, said about it here.
Elizabeth Fowler brings combination of Capitol Hill, White House and pharma industry experience to the role of director of the Center for Medicare and Medicaid Innovation.